By GlobeNewswire Engineered for Exceptional Deliverability, Advanced DES Technology Features Thinner Struts, Enhanced Visibility and the Broadest Size Matrix in the U.S. DUBLIN – May 1, 2017 -Medtronic plc (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Resolute Onyx(TM) Drug-Eluting Stent (DES). […]
Coronary/Structural Heart
Venus Medtech’s TAVR Device Is Approved By CFDA, Creating A New Era Of Interventional Cardiology In China
HANGZHOU, China, April 28, 2017 /PRNewswire/ — Venus Medtech (Hangzhou) Inc., announced on April 25th that its transcatheter aortic valve system – Venus A-valve – has been approved by China Food and Drug Administration(“CFDA”) (registration no.: 20173460680) for sale in China. This marks the first-ever CFDA approved Transcatheter Aortic Valve Implantation […]
Fluctuations in Weight Leads to Dramatically Increased Risks for Cardiac Patients
By Ken Dropiewski Weight loss has always been suggested for those with a body mass index (BMI) over 30 in patients with cardiovascular disease as we know that obesity contributes to poor cardiac outcomes in that segment. However, a new study suggests that patients who experience a fluctuation in body […]
Corindus Vascular Robotics Announces Live Broadcast Of Robotic-Assisted PCI Using CorPath GRX To TCT Asia-Pacific Summit In South Korea
Procedure transmitted live from Fu Wai Hospital to over 4,000 attendees at 22nd annual TCT Asia-Pacific Cardiovascular Summit WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, announced today that Fu Wai Hospital in China performed and broadcast live a PCI procedure using […]
Corindus Vascular Robotics Announces Strategic Partnership With BLOXR Solutions To Distribute Line Of Radiation Protection Products
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, announced today a strategic partnership with BLOXR Solutions, a leading provider of radiation protection products designed to reduce exposure for clinicians and patients. The three-year distribution agreement grants Corindus the non-exclusive rights to distribute […]
Lessons We Can Learn From the Abbott BVS Data
By Ken Dropkiewski The bioresorbable stent was approved for use by the FDA in July of 2016. The Absorb GT1 Bioresorbable Vascular Scaffold System, manufactured by Abbott, was all set to solve a litany of the problems inherent with conventional cardiac and vascular stents. Conventional stents, made of flexible metal […]
Terumo Cardiovascular Group Announces New President and CEO, Robert DeRyke
ANN ARBOR, Mich., April 6, 2017 /PRNewswire/ — Terumo Cardiovascular (CV) Group today announced that Robert (Rob) DeRyke has been appointed President and CEO of Terumo CV Group, effective April 1, 2017, following the retirement of long-time President and CEO Mark Sutter. In this position, DeRyke will lead Terumo’s global business […]
First patient enrolled in major new study investigating abbreviated DAPT post-stent in high bleeding risk patients
PCRonline/News/Industry Press Releases – 04 April, 2017 MASTER-DAPT kicks-off with the enrolment of its first patient by Treant Zorggroep, Scheper Hospital Emmen, The Netherlands – Dr Gillian Jessurun from Treant Zorggroep, Scheper Hospital has enrolled the first patient in the investigator initiated MASTER DAPT (MAnagement of patients post bioresorbable polymer STEnt […]
Cordis, a Cardinal Health Company, introduces innovative products at EUROPCR 2017 to rapidly expand interventional cardiology offering
PCRonline/News/Industry Press Releases – 15 May, 2017 DUBLIN, Ohio. Cordis, Cardinal Health‘s interventional vascular business, announced today the commercial launch of three new products that further enhance its interventional cardiology product portfolio in Europe, the Middle East, and Africa (EMEA). The addition of the Cordis RAILWAY Sheathless Access System as well […]
Occlutech Obtains European CE Mark for its Novel PmVSD Occluder
NEWS PROVIDED BY – Occlutech – 05 Apr, 2017, 07:00 ET SCHAFFHAUSEN, Switzerland, April 5, 2017 /PRNewswire/ — Occlutech, a leading innovator of implants to treat structural heart disease, today announced that it has obtained European CE Mark approval for its Perimembranous Ventricular Septal Defect (PmVSD) Occluder. The device is a […]